Shuangping Li, Gansu Provincial Cancer Hospital, 2 Xiaoxihu East Street, Qilihe District, Lanzhou, China. Emails:
J Nutr Health Aging. 2023;27(11):1140-1146. doi: 10.1007/s12603-023-2028-4.
Probiotics may be an effective alternative to traditional drug therapy for constipation in the elderly.
To assess the efficacy and safety of probiotics in managing constipation among the elderly.
Eight databases were queried for randomized controlled trials (RCTs) investigating probiotics' efficacy in addressing constipation among the elderly until January 2023. The meta-analysis was conducted employing R software version 4.2.2. The Cochrane risk of bias tool was utilized to evaluate the risk of bias, and the GRADE approach was employed to assess the credibility of the evidence concerning the efficacy of probiotics in treating constipation in older individuals.
A total of six RCTs involving 444 patients were included. Two studies were rated as low risk of bias. The meta-analysis findings revealed that probiotics, when compared to a placebo, led to an increase in stool frequency (MD = 1.02,95% CI [0.21, 2.07], p<0.05, very low quality), the probiotic group exhibited a notable impact on ameliorating symptoms associated with constipation (OR = 11.28, 95%CI [7.21, 17.64], p < 0.05, very low quality), no significant disparities were observed in terms of efforts to evacuate, manual maneuvers, and the incidence of adverse events (p>0.05).
The available evidence indicates a degree of uncertainty, ranging from low-to-very low, suggesting the efficacy of probiotics in augmenting bowel frequency and ameliorating constipation-related symptoms among elderly patients with constipation. Nevertheless, given the quality of the studies included, it is advisable to conduct further well-designed investigations with substantial sample sizes to substantiate the findings of this study.
益生菌可能是治疗老年人便秘的一种有效替代传统药物治疗的方法。
评估益生菌治疗老年人便秘的疗效和安全性。
检索了截至 2023 年 1 月的 8 个数据库,以寻找关于益生菌治疗老年人便秘疗效的随机对照试验(RCT)。使用 R 软件版本 4.2.2 进行荟萃分析。使用 Cochrane 偏倚风险工具评估偏倚风险,并使用 GRADE 方法评估关于益生菌治疗老年人便秘疗效的证据的可信度。
共纳入 6 项 RCT,涉及 444 名患者。其中 2 项研究被评为低偏倚风险。荟萃分析结果显示,与安慰剂相比,益生菌组的粪便频率增加(MD=1.02,95%CI[0.21, 2.07],p<0.05,极低质量),益生菌组对改善便秘相关症状有显著影响(OR=11.28,95%CI[7.21, 17.64],p<0.05,极低质量),在排便努力、手动操作和不良事件发生率方面没有显著差异(p>0.05)。
现有证据存在一定程度的不确定性,从低到极低不等,表明益生菌在增加便秘老年人的排便频率和改善便秘相关症状方面具有一定的疗效。然而,鉴于纳入研究的质量,建议进行进一步的精心设计、大样本量的研究,以证实本研究的结果。